Effect of cell culture conditions on the anticytomegalovirus activity of maribavir (Q41473772)

1 October 2017

Effect of cell culture conditions on the anticytomegalovirus activity of maribavir (English)

1 reference

1 October 2017

Sunwen Chou

1

1 reference

1 October 2017

Laura C Van Wechel

series ordinal

2

1 reference

1 October 2017

Gail I Marousek

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Antimicrobial Agents and Chemotherapy

1 October 2017

1 reference

1 October 2017

50

1 reference

1 October 2017

7

1 reference

1 October 2017

2557-2559

1 reference

Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

The pleiotropic effects of mTor inhibitors

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1489798

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide

11 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16801445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00207-06

1 reference

release_tr52fs4p3ngivmw2oj6u4ew2sq

1 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tr52fs4p3ngivmw2oj6u4ew2sq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

1 October 2017

1 reference